Michael Dziegelewski
8Patents
1h-index
31Co-inventors
43Inventor score
Filing activity: Nov 6, 2017 → Mar 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10793634B2 | Anti-TrkB antibodies | Chemistry; Metallurgy | 2 | Active |
| US11332541B2 | Multi-specific binding proteins for cancer treatment | Chemistry; Metallurgy | 1 | Active |
| US10377804B2 | Anti-BAFF antibodies | Chemistry; Metallurgy | 1 | Active |
| US11396539B2 | Anti-ANGPT2 antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11866501B2 | Anti-TrkB antibodies | Chemistry; Metallurgy | 0 | Active |
| US12173083B2 | Multi-specific binding proteins for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US11732045B2 | Multi-specific binding proteins for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US11370818B2 | Anti-BAFF antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.